Vitamin D receptor (VDR) is a nuclear receptor for 1α,25-dihydroxyvitamin D_3 (1α,25(OH)_2D_3), and is an attractive target for multiple clinical applications. We have developed two series of novel VDR agonists with different spherical hydrophobic cores, that is, p-carborane (1,12-dicarba-closo-dodecaborane, an icosahedral carbon-containing boron cluster having remarkable thermal and chemical stability) derivatives and bicyclo[2.2.2]octane derivatives. The carborane-based VDR ligands exhibited significant vitamin D activity, comparable to that of the natural hormone, despite its simple structure with flexible skeletal chains. On the other hand, bicyclo[2.2.2]octane derivatives exhibited quite low activity in comparison to the corresponding carborane derivatives. X-ray crystal structure analysis revealed that the binding of the carborane cage to the hydrophobic surface of the ligand-binding pocket of the receptor could promote transition to the active conformation of VDR. These results also suggested that carborane could function efficiently as a hydrophobic anchor in binding to the receptor surface, thereby allowing induced fitting of the three essential hydroxyl groups, despite the entropic disadvantage of the flexible structure. Such a characteristic structure-activity relationship (SAR) of novel non-secosteroidal VDR ligands based on spherical hydrophobic core and information on SAR are thought to contribute to further development of novel VDR ligands which can be applied to medicines.
抄録全体を表示